I’m Daniel Chandra, a medical oncologist specializing in acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms, and multiple myeloma. 

I offer hematopoietic cell transplantation and cell therapies as treatment options.

What I value most in my work is the deeply personal connections I form with patients, guiding them from diagnosis through treatment. I am privileged to work with a multi-disciplinary and highly specialized team of nurses, advanced practice providers, social workers, and transplant coordinators who aim to create the best individualized treatment plan for each patient.

Dr. Chandra's clinical and research interests include optimizing transplant outcomes for high risk myeloid malignancies, exploring novel strategies to prevent graft-versus-host-disease, and studying the immunobiology of AML. He is a co-investigator on multiple clinical trials at OHSU actively enrolling patients, and has presented his research at national conferences, including the American Society of Hematology and American Society for Transplantation and Cellular Therapy annual meetings.